CPG Clopidogrel

Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. CPG Clopidrogel reduces the risk of heart attacks and strokes (which usually are caused by blood clots) increase in patients with a recent history of stroke or heart attack, and patients with peripheral vascular disease. CPG Clopidrogel film-coated tablets come in a 2x10 blister pack and each film-coated tablet contains:

Clopidrogel bisulfate 97.9mg equivalent to Clopidrogel base 75mg.

CPG ® is indicated for the following

  • Recent miocard infark, recent stroke or established peripheral arterial disease
  • Non-ST degment elevation acute coronary syndrome in combination with Acetosal

CPG ® indications include:.

  • Patients with hypersensitivity to its components and also in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage
  • Breast feeding
  • Severe liver impairment

CPG Clopidrogel is recommended by ACC/AHA & ESC Guidelines

Clopidogrel treating patients with history of heart attack, stroke, peripheral vascular diseases, cerebrovascular diseases.

CPG Clopidogrel

Orange Group Nigeria | Registered office at 66/68 Town Planning way, illupeju, Lagos, Nigeria | Contact Number -+234-0-7098147939